Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.23 | 14.29 |
| PEG Ratio (TTM) | 0.01 | -4.45 |
| P/S Ratio (TTM) | 0.35 | 2.12 |
| P/B Ratio (TTM) | 3.74 | 5.90 |
| P/FCF Ratio (TTM) | 8.12 | 20.92 |
| Price to 5YR AVG Earnings Ratio | 12.14 | 25.53 |
| Price to 5YR AVG FCF Ratio | 8.34 | 28.53 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -15.99% | 9.06% |
| ROE (TTM) | -50.40% | 39.24% |
| Net Profit Margin (TTM) | -10.94% | 13.47% |
| ROIC 5YR AVG | 18.90% | 14.81% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -316.59% | -25.51% | 1,995.99% |
| Revenue | -7.06% | -4.04% | 5.60% |
| Net Income | -313.41% | -26.17% | 1,914.33% |
| Cash Flow | 108.36% | -30.37% | 365.52% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.88 | 2.33 |
| Quick Ratio (TTM) | 1.12 | 1.85 |
| D/E Ratio (TTM) | 1.98 | 2.09 |
| Interest Coverage (TTM) | -15.03 | 13.63 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 1.49 | 3.39 |
| LTL to 5YR AVG FCF | 4.72 | 7.29 |
| Shares Outstanding Growth 5YR AVG | -3.78% | -2.05% |